Displaying 1 result from an estimated 1 matches for "tivozanib".
2010 Aug 20
0
Wanted :BioInformatics Scientist - Heavy "R" focus
...excellent communication skills are preferred.
About AVEO
AVEO Pharmaceuticals (NASDAQ: AVEO) integrates a proprietary cancer
biology platform with drug development and commercial expertise in its
efforts to discover and develop targeted cancer therapeutics. The
company's lead product, Tivozanib, is an oral, triple VEGF receptor
inhibitor with potential for a best-in-class profile. Tivozanib is
currently being investigated in a global, randomized Phase 3 clinical
trial called TIVO-1
<http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.ave
opharma.com%2Ffor_patients%2...